PMID: 9448296Mar 14, 1998Paper

Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent

Proceedings of the National Academy of Sciences of the United States of America
S E AndrewFrank R Jirik

Abstract

The mutational response of mismatch repair-deficient animals to the alkylating agent N-methyl-N-nitrosourea was evaluated by using a transgenic lacI reporter system. Although the mutations detected in MSH2 heterozygotes were similar to those of controls, MSH2-/- animals demonstrated striking increases in mutation frequency in response to this agent. G:C to A:T transitions at GpG sites, as opposed to CpG sites, dominated the mutational spectrum of both MSH2+/+ and MSH2-/- N-methyl-N-nitrosourea -treated animals. Extrapolating to humans with hereditary non-polyposis colorectal cancer, the results suggest that MSH2 heterozygotes are unlikely to be at increased risk of mutation, even when exposed to potent DNA methylating agents. In contrast, mismatch repair-deficient cells spontaneously arising within individuals with hereditary non-polyposis colorectal cancer would likely exhibit hypermutability in response to such mutagens, an outcome predicted to accelerate the pace of tumorigenesis.

References

Jun 25, 1992·Nucleic Acids Research·P Karran, M Bignami
Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S W KohlerJ M Short
Jul 1, 1991·British Journal of Cancer·C N HallR Saffhill
Jul 1, 1991·Carcinogenesis·J L GreenG A Reed
Dec 1, 1990·Genetic Analysis, Techniques and Applications·S W KohlerJ M Short
Jan 1, 1990·Environmental and Molecular Mutagenesis·M J HorsfallB W Glickman
Jul 1, 1989·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·F W WardR Walker
Jun 1, 1988·Mutation Research·A J Gordon, B W Glickman
Sep 1, 1988·Chemical Research in Toxicology·M A Marletta
Jan 1, 1987·Molecular and Cellular Biology·R B DuBridgeM P Calos
May 1, 1988·Molecular and Cellular Biology·L E DiamondA Pellicer
Dec 1, 1987·Environmental Health Perspectives·B W GlickmanP A Burns
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·K K RichardsonT R Skopek
Jan 1, 1995·Mutation Research·M Batiste-AlentornR Marcos
Jun 1, 1995·Current Opinion in Genetics & Development·R Fishel, R D Kolodner
Sep 1, 1995·Nature Genetics·A H ReitmairB Liu
Jul 1, 1993·Mutation Research·G S ProvostJ M Short
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A KatP Modrich
Oct 1, 1995·Trends in Biochemical Sciences·R D Kolodner
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·L NarayananP M Glazer

❮ Previous
Next ❯

Citations

Mar 25, 2005·Annals of Hematology·Josep F NomdedéuJorge Sierra
Oct 12, 2000·Mutation Research·O J Sansom, A R Clarke
Dec 10, 2002·Mechanisms of Ageing and Development·Tetsuya OnoHironobu Ikehata
Mar 20, 2002·Biochimie·Sandrine Jacob, Françoise Praz
Jul 13, 2002·Trends in Molecular Medicine·Kaichun WeiWinfried Edelmann
Jan 13, 2012·Nature Reviews. Cancer·Dragony FuLeona D Samson
Oct 18, 2001·Journal of the National Cancer Institute·C ColussiM Bignami
Feb 24, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D B Winter, P J Gearhart
Mar 4, 2000·Journal of Medical Genetics·R S Houlston, I P Tomlinson
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·C Flores, W Engels
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Edmund WongWinfried Edelmann
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·A Baross-FrancisF R Jirik
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·A KlunglandD E Barnes
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·N J ToftA R Clarke
Apr 1, 2008·Experimental Cell Research·Elisia D Tichy, Peter J Stambrook
Oct 28, 2008·Human Mutation·Robert M W HofstraUNKNOWN IARC Unclassified Genetic Variants Working Group
Feb 26, 2000·Annual Review of Genetics·A B BuermeyerR M Liskay
Apr 24, 2013·Therapeutic Advances in Hematology·Raymond Lai, Robert J Ingham
Dec 19, 2002·Environmental and Molecular Mutagenesis·Shulin ZhangJohan G de Boer
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Shanbeh ZienolddinyAage Haugen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.